Résultats de la recherche - 106 results
Diagnostic testing in myeloid malignancies by next-generation sequencing: recommendations from the commission personalised medicine
E Heylen; K Jacobs; F Lambert; Marie Le Mercier; Els Lierman; H Louagie; B Maes; MB Maes; G Martens; L Michaux; Friedel Nollet; H A Poirel; G Raicevic; P Saussoy; T Tousseyn; Marc Van den Bulcke; ...
Des patients cancéreux parlent du ngs: Étude de groupe de discussion sur les expériences et les besoins en information
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Wannes Van Hoof; Katrien Moens Source: Sciensano, Brussels, Belgium, p.29 (2019) Keywords: NGS Patient ...
Molecular test algorithms for breast tumours
S Dedeurwaerdere; J De Grève; A de Leener; H Denys; R de Putter; L Desmyter; M Baldewijns; D Feret; C Fontaine; C Galant; P Hilbert; J Janssens; D Larsimont; P Lefesvre; T Sticca; MD Tkint de Roodenbeke; I Vanden ...
Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis.
Publication Type: Peer reviewed scientific article Authors: Mena, Marisa; Taberna, Miren; Laura Monfil; M. Arbyn; de Sanjosé, Silvia; Bosch, Francesc Xavier; Alemany, Laia; Bruni, Laia Source: ...
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
0.78-0.97; ratio for LSIL, 0.86; 95% CI, 0.80-0.93). In contrast, the specificity of p16 staining was substantially higher with relative specificities of 1.60 (95% CI, 1.35-1.88) and 2.29 (95% CI, 2.05-2.56) ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.
Karsten; Schneider, Achim; Kaufmann, Andreas; Petry, K Ulrich; Axel P A Schäfer; Pawlita, Michael; Weis, Joachim; Mehnert, Anja; Fehr, Mathias; Grimm, Christoph; Reich, Olaf; M. Arbyn; Kleijnen, Jos; ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
Karsten; Schneider, Achim; Kaufmann, Andreas; Petry, K Ulrich; Axel P A Schäfer; Pawlita, Michael; Weis, Joachim; Mehnert, Anja; Fehr, Mathias; Grimm, Christoph; Reich, Olaf; M. Arbyn; Kleijnen, Jos; ...
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
Publication Type: Peer reviewed scientific article Authors: Fröberg, Maria; Östensson, Ellinor; Belkić, Karen; Anja Oštrbenk; Poljak, Mario; Mints, Miriam; M. Arbyn; Andersson, Sonia Source: Cancer, ...
The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer
colorectal, breast, head & neck, prostate, testis, lung and corpus uteri cancer. The end of (administrative) follow-up was 31st December 2012. We include demographic, health-related and work-related factors ...
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia
Adam; Butler, Katherine; Darlington-Brown, Jessica; Hui, Harriet; Brotherton, Julia; Skinner, Rachel; Brand, A; Roeske, Lara; Heley, Stella; Carter, Jonathan; Bateson, Deborah; Frazer, Ian; Garland, ...